Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.49 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | MAPT | P10636 | 3/20 | 0.43 |
| ▸ | ACHE | P22303 | 3/20 | 0.43 |
| ▸ | MEN1 | O00255 | 2/20 | 0.43 |
| ▸ | CNR1 | P21554 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.42 |
| ▸ | CFTR | P13569 | 3/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | CXCR3 | P49682 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7745218 | 0.77 | MAPT (0.52) | CNR2KMT2AMAPTACHEMEN1 | |
| SCHEMBL7745456 | 0.74 | TSHR (0.61) | TSHRMAPK1KMT2AMAPTMEN1 | |
| SCHEMBL7745460 | 0.74 | TSHR (0.61) | TSHRMAPK1KMT2AMAPTMEN1 | |
| SCHEMBL7745027 | 0.72 | TSHR (0.58) | TSHRMAPK1KMT2AMAPTMEN1 | |
| SCHEMBL7745229 | 0.72 | TSHR (0.50) | CNR2TSHRMAPK1KMT2AMAPT | |
| SCHEMBL7745601 | 0.72 | TSHR (0.68) | TSHRMAPK1KMT2AMAPTMEN1 | |
| SCHEMBL22151047 | 0.71 | CNR2 (0.58) | CNR2KMT2AMAPTACHEMEN1 | |
| Hydrochloric Acid SCHEMBL5858859 | 0.71 | TSHR (0.70) | TSHRMAPK1KMT2AMAPTMEN1 | |
| SCHEMBL22151026 | 0.71 | MAPT (0.52) | CNR2KMT2AMAPTACHEMEN1 | |
| SCHEMBL5859138 | 0.70 | TSHR (0.65) | TSHRMAPK1KMT2AMAPTMEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |
| US-6774134-B2 | FOR THERAPY OF RESPIRATORY SYNCYTIAL VIRUS INFECTION | BRISTOL-MYERS SQUIBB COMPANY | 2004-08-10 | — | — | US | disclosed |